TCL Archive In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years October 7, 1977
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: USC Norris Opens Topping Tower March 21; Postal Service To Sell Breast Cancer Stamps March 15, 1996
